Study highlights the need to train health professionals on gluten-free diet

According to a study by the University of the Basque Country (UPV/EHU), the Internet is the go-to source for most people with celiac disease when tackling their dietary queries.

Esprit Resorbable Scaffold Triumphs for Severe PAD Below the Knee

SAN FRANCISCO — The Esprit BTK drug-eluting resorbable scaffold proved safe and effective for patients with chronic limb-threatening ischemia (CLTI) and infrapopliteal artery disease, the

October 26, 2023

Risk Adjusted Net Present Value: What is the current valuation of 180 Life Sciences’s Fibrosis and anti-TNF

The revenue for Fibrosis and anti-TNF is expected to reach an annual total of $140 mn by 2037 globally based off GlobalData’s Expiry Model. The

August 28, 2023

Pharmalittle: We’re reading about an FDA hold on an Amgen obesity drug, imported Canadian drugs, and more

Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. After

February 5, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.